UniProt ID | SAHH2_HUMAN | |
---|---|---|
UniProt AC | O43865 | |
Protein Name | S-adenosylhomocysteine hydrolase-like protein 1 {ECO:0000312|HGNC:HGNC:344} | |
Gene Name | AHCYL1 {ECO:0000312|HGNC:HGNC:344} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 530 | |
Subcellular Localization | Endoplasmic reticulum . Cytoplasm, cytosol . Microsome . Apical cell membrane . Associates with membranes when phosphorylated, probably through interaction with ITPR1. | |
Protein Description | Multifaceted cellular regulator which coordinates several essential cellular functions including regulation of epithelial HCO3(-) and fluid secretion, mRNA processing and DNA replication. Regulates ITPR1 sensitivity to inositol 1,4,5-trisphosphate competing for the common binding site and acting as endogenous 'pseudoligand' whose inhibitory activity can be modulated by its phosphorylation status. In the pancreatic and salivary ducts, at resting state, attenuates inositol 1,4,5-trisphosphate-induced calcium release by interacting with ITPR1. [PubMed: 16793548 When extracellular stimuli induce ITPR1 phosphorylation or inositol 1,4,5-trisphosphate production, dissociates of ITPR1 to interact with CFTR and SLC26A6 mediating their synergistic activation by calcium and cAMP that stimulates the epithelial secretion of electrolytes and fluid (By similarity Also activates basolateral SLC4A4 isoform 1 to coordinate fluid and HCO3(-) secretion] | |
Protein Sequence | MSMPDAMPLPGVGEELKQAKEIEDAEKYSFMATVTKAPKKQIQFADDMQEFTKFPTKTGRRSLSRSISQSSTDSYSSAASYTDSSDDEVSPREKQQTNSKGSSNFCVKNIKQAEFGRREIEIAEQDMSALISLRKRAQGEKPLAGAKIVGCTHITAQTAVLIETLCALGAQCRWSACNIYSTQNEVAAALAEAGVAVFAWKGESEDDFWWCIDRCVNMDGWQANMILDDGGDLTHWVYKKYPNVFKKIRGIVEESVTGVHRLYQLSKAGKLCVPAMNVNDSVTKQKFDNLYCCRESILDGLKRTTDVMFGGKQVVVCGYGEVGKGCCAALKALGAIVYITEIDPICALQACMDGFRVVKLNEVIRQVDVVITCTGNKNVVTREHLDRMKNSCIVCNMGHSNTEIDVTSLRTPELTWERVRSQVDHVIWPDGKRVVLLAEGRLLNLSCSTVPTFVLSITATTQALALIELYNAPEGRYKQDVYLLPKKMDEYVASLHLPSFDAHLTELTDDQAKYLGLNKNGPFKPNYYRY | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 (in isoform 2) | Acetylation | - | 7.55 | 22814378 | |
2 | Acetylation | ------MSMPDAMPL ------CCCCCCCCC | 38.74 | 20068231 | |
2 | Phosphorylation | ------MSMPDAMPL ------CCCCCCCCC | 38.74 | 29255136 | |
3 | Sulfoxidation | -----MSMPDAMPLP -----CCCCCCCCCC | 3.17 | 28183972 | |
7 | Sulfoxidation | -MSMPDAMPLPGVGE -CCCCCCCCCCCCCH | 4.58 | 28183972 | |
27 | Acetylation | KEIEDAEKYSFMATV HCHHHHHHHCEEEEE | 48.17 | 26051181 | |
28 | Phosphorylation | EIEDAEKYSFMATVT CHHHHHHHCEEEEEC | 9.92 | 25159151 | |
29 | Phosphorylation | IEDAEKYSFMATVTK HHHHHHHCEEEEECC | 21.44 | 18707149 | |
31 | Sulfoxidation | DAEKYSFMATVTKAP HHHHHCEEEEECCCC | 2.22 | 30846556 | |
33 | Phosphorylation | EKYSFMATVTKAPKK HHHCEEEEECCCCHH | 19.54 | 26356563 | |
35 | Phosphorylation | YSFMATVTKAPKKQI HCEEEEECCCCHHHC | 19.68 | 46160637 | |
36 | Acetylation | SFMATVTKAPKKQIQ CEEEEECCCCHHHCC | 59.35 | 25953088 | |
40 | Acetylation | TVTKAPKKQIQFADD EECCCCHHHCCCCHH | 52.12 | 26051181 | |
40 | Ubiquitination | TVTKAPKKQIQFADD EECCCCHHHCCCCHH | 52.12 | - | |
48 | Sulfoxidation | QIQFADDMQEFTKFP HCCCCHHHHHHHCCC | 4.18 | 21406390 | |
53 | Ubiquitination | DDMQEFTKFPTKTGR HHHHHHHCCCCHHCC | 55.45 | - | |
57 | Ubiquitination | EFTKFPTKTGRRSLS HHHCCCCHHCCHHHH | 49.58 | - | |
58 | Phosphorylation | FTKFPTKTGRRSLSR HHCCCCHHCCHHHHH | 38.10 | 28102081 | |
62 | Phosphorylation | PTKTGRRSLSRSISQ CCHHCCHHHHHHHCC | 29.36 | 28102081 | |
64 | Phosphorylation | KTGRRSLSRSISQSS HHCCHHHHHHHCCCC | 25.81 | 28102081 | |
66 | Phosphorylation | GRRSLSRSISQSSTD CCHHHHHHHCCCCCC | 24.18 | 23090842 | |
68 | Phosphorylation | RSLSRSISQSSTDSY HHHHHHHCCCCCCCC | 25.84 | 16793548 | |
70 | Phosphorylation | LSRSISQSSTDSYSS HHHHHCCCCCCCCCC | 28.54 | 68737123 | |
71 | Phosphorylation | SRSISQSSTDSYSSA HHHHCCCCCCCCCCC | 28.70 | 16793548 | |
72 | Phosphorylation | RSISQSSTDSYSSAA HHHCCCCCCCCCCCC | 33.92 | 30576142 | |
74 | Phosphorylation | ISQSSTDSYSSAASY HCCCCCCCCCCCCCC | 27.31 | 26657352 | |
75 | Phosphorylation | SQSSTDSYSSAASYT CCCCCCCCCCCCCCC | 14.95 | 26434776 | |
76 | Phosphorylation | QSSTDSYSSAASYTD CCCCCCCCCCCCCCC | 19.90 | 23090842 | |
77 | Phosphorylation | SSTDSYSSAASYTDS CCCCCCCCCCCCCCC | 21.44 | 19220705 | |
80 | Phosphorylation | DSYSSAASYTDSSDD CCCCCCCCCCCCCCC | 28.43 | 23090842 | |
81 | Phosphorylation | SYSSAASYTDSSDDE CCCCCCCCCCCCCCC | 15.16 | 23090842 | |
82 | Phosphorylation | YSSAASYTDSSDDEV CCCCCCCCCCCCCCC | 27.23 | 28857561 | |
84 | Phosphorylation | SAASYTDSSDDEVSP CCCCCCCCCCCCCCH | 28.06 | 28857561 | |
85 | Phosphorylation | AASYTDSSDDEVSPR CCCCCCCCCCCCCHH | 52.47 | 28857561 | |
90 | Phosphorylation | DSSDDEVSPREKQQT CCCCCCCCHHHHHCC | 19.05 | 110736801 | |
100 | Acetylation | EKQQTNSKGSSNFCV HHHCCCCCCCCCCCH | 65.95 | 26051181 | |
100 | Ubiquitination | EKQQTNSKGSSNFCV HHHCCCCCCCCCCCH | 65.95 | - | |
102 | Phosphorylation | QQTNSKGSSNFCVKN HCCCCCCCCCCCHHC | 26.33 | 28102081 | |
103 | Phosphorylation | QTNSKGSSNFCVKNI CCCCCCCCCCCHHCH | 42.46 | 28102081 | |
108 | Acetylation | GSSNFCVKNIKQAEF CCCCCCHHCHHHHHH | 54.88 | 25953088 | |
108 | Ubiquitination | GSSNFCVKNIKQAEF CCCCCCHHCHHHHHH | 54.88 | - | |
111 | 2-Hydroxyisobutyrylation | NFCVKNIKQAEFGRR CCCHHCHHHHHHCCC | 53.50 | - | |
111 | Acetylation | NFCVKNIKQAEFGRR CCCHHCHHHHHHCCC | 53.50 | 25953088 | |
111 | Ubiquitination | NFCVKNIKQAEFGRR CCCHHCHHHHHHCCC | 53.50 | - | |
127 | Sulfoxidation | IEIAEQDMSALISLR EEEHHHHHHHHHHHH | 2.23 | 30846556 | |
141 | Acetylation | RKRAQGEKPLAGAKI HHHHCCCCCCCCCEE | 52.75 | 25953088 | |
141 | Ubiquitination | RKRAQGEKPLAGAKI HHHHCCCCCCCCCEE | 52.75 | - | |
239 | Acetylation | DLTHWVYKKYPNVFK CHHHHHHHHCCCHHH | 35.89 | 26051181 | |
240 | Acetylation | LTHWVYKKYPNVFKK HHHHHHHHCCCHHHH | 48.53 | 27452117 | |
240 | Ubiquitination | LTHWVYKKYPNVFKK HHHHHHHHCCCHHHH | 48.53 | - | |
246 | Acetylation | KKYPNVFKKIRGIVE HHCCCHHHHHHHHHH | 42.90 | 25953088 | |
249 | Methylation | PNVFKKIRGIVEESV CCHHHHHHHHHHHHC | 37.35 | - | |
255 (in isoform 2) | Ubiquitination | - | 16.09 | 21906983 | |
257 | Phosphorylation | GIVEESVTGVHRLYQ HHHHHHCCHHHHHHH | 42.64 | - | |
263 | Phosphorylation | VTGVHRLYQLSKAGK CCHHHHHHHHHHCCC | 13.83 | 6831211 | |
267 | 2-Hydroxyisobutyrylation | HRLYQLSKAGKLCVP HHHHHHHHCCCEEEE | 70.52 | - | |
267 | Acetylation | HRLYQLSKAGKLCVP HHHHHHHHCCCEEEE | 70.52 | 25953088 | |
267 | Malonylation | HRLYQLSKAGKLCVP HHHHHHHHCCCEEEE | 70.52 | 26320211 | |
267 | Ubiquitination | HRLYQLSKAGKLCVP HHHHHHHHCCCEEEE | 70.52 | - | |
270 | Acetylation | YQLSKAGKLCVPAMN HHHHHCCCEEEEECC | 43.50 | 25953088 | |
270 | Malonylation | YQLSKAGKLCVPAMN HHHHHCCCEEEEECC | 43.50 | 26320211 | |
270 | Ubiquitination | YQLSKAGKLCVPAMN HHHHHCCCEEEEECC | 43.50 | - | |
272 | S-nitrosylation | LSKAGKLCVPAMNVN HHHCCCEEEEECCCC | 3.82 | 24105792 | |
276 | Sulfoxidation | GKLCVPAMNVNDSVT CCEEEEECCCCCHHH | 4.75 | 21406390 | |
281 | Phosphorylation | PAMNVNDSVTKQKFD EECCCCCHHHHHHCC | 26.87 | 20068231 | |
283 | Phosphorylation | MNVNDSVTKQKFDNL CCCCCHHHHHHCCCE | 31.54 | 20068231 | |
284 | Ubiquitination | NVNDSVTKQKFDNLY CCCCHHHHHHCCCEE | 49.70 | - | |
286 | 2-Hydroxyisobutyrylation | NDSVTKQKFDNLYCC CCHHHHHHCCCEEEH | 57.13 | - | |
286 | Acetylation | NDSVTKQKFDNLYCC CCHHHHHHCCCEEEH | 57.13 | 26051181 | |
286 | Ubiquitination | NDSVTKQKFDNLYCC CCHHHHHHCCCEEEH | 57.13 | - | |
302 | Ubiquitination | ESILDGLKRTTDVMF HHHHHHHCCCCCEEE | 53.91 | 21906983 | |
302 (in isoform 1) | Ubiquitination | - | 53.91 | 21906983 | |
308 | Sulfoxidation | LKRTTDVMFGGKQVV HCCCCCEEECCEEEE | 2.62 | 21406390 | |
359 | 2-Hydroxyisobutyrylation | MDGFRVVKLNEVIRQ HCCCEEEEHHHHHHC | 42.62 | - | |
359 | Acetylation | MDGFRVVKLNEVIRQ HCCCEEEEHHHHHHC | 42.62 | 25953088 | |
359 | Ubiquitination | MDGFRVVKLNEVIRQ HCCCEEEEHHHHHHC | 42.62 | - | |
372 | Phosphorylation | RQVDVVITCTGNKNV HCCCEEEECCCCCCE | 7.75 | 68726059 | |
374 | Phosphorylation | VDVVITCTGNKNVVT CCEEEECCCCCCEEC | 34.83 | 68726065 | |
385 (in isoform 2) | Ubiquitination | - | 3.70 | 21906983 | |
389 | Ubiquitination | REHLDRMKNSCIVCN HHHHHHHCCCEEEEE | 46.75 | - | |
391 | Phosphorylation | HLDRMKNSCIVCNMG HHHHHCCCEEEEECC | 10.33 | 19224921 | |
400 | Phosphorylation | IVCNMGHSNTEIDVT EEEECCCCCCEEEEC | 39.45 | 18669648 | |
402 | Phosphorylation | CNMGHSNTEIDVTSL EECCCCCCEEEECCC | 37.01 | 18669648 | |
407 | Phosphorylation | SNTEIDVTSLRTPEL CCCEEEECCCCCCCC | 20.49 | 18669648 | |
411 | Phosphorylation | IDVTSLRTPELTWER EEECCCCCCCCCHHH | 26.80 | 21406692 | |
415 | Phosphorylation | SLRTPELTWERVRSQ CCCCCCCCHHHHHHH | 24.50 | 21406692 | |
418 | Methylation | TPELTWERVRSQVDH CCCCCHHHHHHHCCE | 22.25 | - | |
421 | Phosphorylation | LTWERVRSQVDHVIW CCHHHHHHHCCEEEC | 31.53 | 24719451 | |
432 | 2-Hydroxyisobutyrylation | HVIWPDGKRVVLLAE EEECCCCCEEEEEEC | 49.77 | - | |
432 | Ubiquitination | HVIWPDGKRVVLLAE EEECCCCCEEEEEEC | 49.77 | 21906983 | |
432 (in isoform 1) | Ubiquitination | - | 49.77 | 21906983 | |
452 | Phosphorylation | LSCSTVPTFVLSITA EECCCCCEEEEEHHH | 23.26 | 22210691 | |
456 | Phosphorylation | TVPTFVLSITATTQA CCCEEEEEHHHHHHH | 16.76 | 22210691 | |
461 | Phosphorylation | VLSITATTQALALIE EEEHHHHHHHHHHHH | 14.91 | 22210691 | |
478 | Acetylation | NAPEGRYKQDVYLLP CCCCCCCCCEEEECC | 38.37 | 26051181 | |
478 | Ubiquitination | NAPEGRYKQDVYLLP CCCCCCCCCEEEECC | 38.37 | - | |
482 | Phosphorylation | GRYKQDVYLLPKKMD CCCCCEEEECCHHHH | 15.71 | 110736809 | |
486 | 2-Hydroxyisobutyrylation | QDVYLLPKKMDEYVA CEEEECCHHHHHHHH | 61.78 | - | |
486 | Ubiquitination | QDVYLLPKKMDEYVA CEEEECCHHHHHHHH | 61.78 | - | |
487 | Ubiquitination | DVYLLPKKMDEYVAS EEEECCHHHHHHHHH | 50.04 | - | |
513 | Ubiquitination | ELTDDQAKYLGLNKN ECCHHHHHHCCCCCC | 35.06 | - | |
524 | Ubiquitination | LNKNGPFKPNYYRY- CCCCCCCCCCCCCC- | 35.17 | - | |
527 | Phosphorylation | NGPFKPNYYRY---- CCCCCCCCCCC---- | 9.61 | 21945579 | |
528 | Phosphorylation | GPFKPNYYRY----- CCCCCCCCCC----- | 15.29 | 21945579 | |
529 | Methylation | PFKPNYYRY------ CCCCCCCCC------ | 21.96 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SAHH2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SAHH2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-391; SER-400; THR-402AND THR-407, AND MASS SPECTROMETRY. | |
"Time-resolved mass spectrometry of tyrosine phosphorylation sites inthe epidermal growth factor receptor signaling network reveals dynamicmodules."; Zhang Y., Wolf-Yadlin A., Ross P.L., Pappin D.J., Rush J.,Lauffenburger D.A., White F.M.; Mol. Cell. Proteomics 4:1240-1250(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-28, AND MASSSPECTROMETRY. |